Total Value
$279.23B
Holdings Count
14
Period of Report
Mar 31, 2025
Report Type
HR
| Issuer | CUSIP | Value | Shares |
|---|---|---|---|
| GH RESEARCH PLC | G3855L106 | $71.08B | 6,443,940 |
| MERUS N V | N5749R100 | $66.03B | 1,568,841 |
| PROTAGONIST THERAPEUTICS INC | 74366E102 | $35.45B | 733,014 |
| STOKE THERAPEUTICS INC | 86150R107 | $35.19B | 5,291,929 |
| CULLINAN THERAPEUTICS INC | 230031106 | $24.34B | 3,215,722 |
| ALLOGENE THERAPEUTICS INC | 019770106 | $16.14B | 11,057,009 |
| C4 THERAPEUTICS INC | 12529R107 | $11.36B | 7,098,133 |
| TSCAN THERAPEUTICS INC | 89854M101 | $7.39B | 5,357,347 |
| PRECISION BIOSCIENCES INC | 74019P207 | $3.65B | 766,051 |
| IBIO INC | 451033708 | $3.47B | 862,279 |
| PASSAGE BIO INC | 702712100 | $3.27B | 9,256,953 |
| UPSTREAM BIO INC | 91678A107 | $1.34B | 219,247 |
| NEUPHORIA THERAPEUTICS INC | 64136E102 | $263.8M | 45,806 |
| DESIGN THERAPEUTICS INC | 25056L103 | $254.6M | 65,954 |